ADMP Insider Trading (Adamis Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $70,646.40

Adamis Pharmaceuticals Insider Trading History Chart

Adamis Pharmaceuticals Share Price & Price History

^$1.12

▲ +0.01 (0.90%)

As of 02/26/2021 01:00 AM ET

Days: 30 | 90 | 365

The END of Capitalism As We Know It?

From Stansberry | Ad

A terrifying (for some) and new disruptive force is creating thousands of new millionaires (Barron’s reports 20,000 to 200,000 so far) while at the same time destroying the financial future for many others.

Don’t get left behind. Get the facts for yourself

Adamis Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/20/2020	David J Marguglio	SVP	Sell	35,000	$0.40	$14,000.00	287,264
9/29/2020	Robert O Hopkins	CFO	Sell	20,000	$0.80	$16,000.00	274,781
8/18/2020	David J. Marguglio	SVP	Sell	8,749	$0.87	$7,611.63
8/18/2020	Dennis J. Phd Carlo	CEO	Sell	10,929	$0.87	$9,508.23
8/18/2020	Karen K. Daniels	VP	Sell	5,480	$0.87	$4,767.60
8/18/2020	Robert O. Hopkins	CFO	Sell	7,418	$0.87	$6,453.66
3/18/2020	Dennis J Phd Carlo	CEO	Sell	10,645	$0.34	$3,619.30	320,089
3/18/2020	Karen K Daniels	VP	Sell	6,461	$0.34	$2,196.74	150,999
3/18/2020	Robert O Hopkins	CFO	Sell	8,749	$0.34	$2,974.66	308,731
3/18/2020	Ronald B Moss	Insider	Sell	10,337	$0.34	$3,514.58	242,858
2/24/2020	David J Marguglio	SVP	Sell	9,948	$0.60	$5,968.80	335,359
2/24/2020	Dennis J Phd Carlo	CEO	Sell	12,436	$0.60	$7,461.60	330,734
2/24/2020	Karen K Daniels	VP	Sell	6,229	$0.60	$3,737.40	157,460
2/24/2020	Robert O Hopkins	CFO	Sell	8,420	$0.60	$5,052.00	317,480
11/18/2019	David J Marguglio	SVP	Sell	8,283	$0.87	$7,206.21	365,307
11/18/2019	Dennis J Phd Carlo	CEO	Sell	10,760	$0.84	$9,038.40	343,170
11/18/2019	Karen K Daniels	VP	Sell	5,421	$0.83	$4,499.43	163,689
11/18/2019	Robert O Hopkins	CFO	Sell	7,347	$0.83	$6,098.01	325,900
11/18/2019	Ronald B Moss	Insider	Sell	8,448	$0.85	$7,180.80	259,424
8/19/2019	David J Marguglio	SVP	Sell	8,109	$1.10	$8,919.90	373,590
8/19/2019	Dennis J Phd Carlo	CEO	Sell	10,477	$1.06	$11,105.62	353,930
8/19/2019	Karen K Daniels	VP	Sell	5,243	$1.06	$5,557.58	169,110
8/19/2019	Robert O Hopkins	CFO	Sell	7,101	$1.06	$7,527.06	333,247
8/19/2019	Ronald B Moss	Insider	Sell	8,383	$1.06	$8,885.98	267,872
5/24/2019	Robert B Rothermel	Director	Buy	6,500	$1.58	$10,270.00	133,500
5/20/2019	David J Marguglio	SVP	Sell	8,735	$1.77	$15,460.95	381,699
5/20/2019	Dennis J Phd Carlo	CEO	Sell	11,184	$1.73	$19,348.32	364,407
5/20/2019	Karen K Daniels	VP	Sell	5,591	$1.73	$9,672.43	174,353
5/20/2019	Robert O Hopkins	CFO	Sell	7,559	$1.73	$13,077.07	340,348
5/20/2019	Ronald B Moss	Insider	Sell	8,741	$1.77	$15,471.57	276,255
3/20/2019	David J Marguglio	SVP	Sell	10,579	$2.28	$24,120.12	390,434
3/20/2019	Dennis J Phd Carlo	CEO	Sell	13,292	$2.27	$30,172.84	42,353
3/20/2019	Karen K Daniels	VP	Sell	13,911	$2.30	$31,995.30	179,944
3/20/2019	Robert O Hopkins	CFO	Sell	8,900	$2.30	$20,470.00	347,907
3/20/2019	Ronald B Moss	Insider	Sell	6,647	$2.27	$15,088.69	284,996

SEC Filings (Institutional Ownership Changes) for Adamis Pharmaceuticals (NASDAQ:ADMP)

7.36% of Adamis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adamis Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/12/2021	Verdence Capital Advisors LLC	58,382	$28K	0.0%	-33.9%	0.065%
2/4/2021	GSA Capital Partners LLP	516,203	$0.25M	0.0%	+825.9%	0.573%
12/11/2020	Virtu Financial LLC	39,683	$31K	0.0%	N/A	0.044%
11/9/2020	Verdence Capital Advisors LLC	88,382	$69K	0.0%	N/A	0.098%
11/6/2020	GSA Capital Partners LLP	55,752	$44K	0.0%	N/A	0.062%
11/2/2020	Level Four Advisory Services LLC	32,000	$25K	0.0%	-40.2%	0.036%
10/29/2020	Cambridge Investment Research Advisors Inc.	46,849	$37K	0.0%	N/A	0.052%
7/31/2020	UBS Group AG	61,575	$33K	0.0%	+426.3%	0.083%
5/15/2020	Sabby Management LLC	88,210	$32K	0.0%	N/A	0.121%
2/20/2020	Geode Capital Management LLC	629,742	$0.44M	0.0%	+86.8%	1.022%
10/17/2019	Wedbush Securities Inc.	86,600	$61K	0.0%	+94.2%	0.141%
8/16/2019	First Manhattan Co.	1,391,733	$1.81M	0.0%	-58.5%	2.265%
8/14/2019	Morgan Stanley	757,124	$0.98M	0.0%	+189.7%	1.589%
8/14/2019	Vanguard Group Inc.	1,791,266	$2.33M	0.0%	+4.5%	3.760%
8/14/2019	A.R.T. Advisors LLC	61,711	$80K	0.0%	+143.8%	0.130%
8/13/2019	BlackRock Inc.	962,687	$1.25M	0.0%	+1.5%	2.021%
8/6/2019	GSA Capital Partners LLP	139,605	$0.18M	0.0%	N/A	0.293%
8/1/2019	Wedbush Securities Inc.	44,600	$58K	0.0%	+139.8%	0.094%
6/30/2019	Leisure Capital Management	22,311	$29K	0.0%	-80.7%	0.047%
5/10/2019	DekaBank Deutsche Girozentrale	1,200,000	$3.36M	0.0%	N/A	2.537%
5/8/2019	National Asset Management Inc.	29,920	$64K	0.0%	+28.9%	0.063%
5/8/2019	Leisure Capital Management	115,724	$0.24M	0.2%	+4.5%	0.245%
4/17/2019	Wedbush Securities Inc.	18,600	$39K	0.0%	N/A	0.039%
4/12/2019	Virtu Financial LLC	20,588	$43K	0.0%	N/A	0.044%
4/12/2019	First Manhattan Co.	3,352,333	$7.07M	0.0%	-2.0%	7.089%
2/15/2019	Jane Street Group LLC	13,740	$31K	0.0%	N/A	0.029%
2/14/2019	Barclays PLC	48,700	$0.11M	0.0%	N/A	0.103%
2/13/2019	Geode Capital Management LLC	301,330	$0.68M	0.0%	+18.9%	0.637%
2/12/2019	Northern Trust Corp	166,170	$0.37M	0.0%	-2.0%	0.351%
2/11/2019	Raymond James Financial Services Advisors Inc.	14,317	$32K	0.0%	-28.9%	0.030%
2/11/2019	Raymond James & Associates	49,596	$0.11M	0.0%	+56.5%	0.105%
2/8/2019	BlackRock Inc.	963,864	$2.17M	0.0%	+8.4%	2.038%
2/7/2019	LPL Financial LLC	15,490	$35K	0.0%	-31.4%	0.033%
2/5/2019	Cambridge Investment Research Advisors Inc.	16,001	$36K	0.0%	N/A	0.034%
1/29/2019	Oppenheimer & Co. Inc.	17,000	$38K	0.0%	N/A	0.036%
12/13/2018	Vanguard Group Inc	1,637,513	$5.73M	0.0%	+27.1%	3.463%
11/23/2018	Vanguard Group Inc.	1,637,513	$5.73M	0.0%	+27.1%	3.463%
11/14/2018	Perceptive Advisors LLC	137,500	$0.48M	0.0%	N/A	0.291%
11/9/2018	DekaBank Deutsche Girozentrale	1,200,000	$3.36M	0.0%	+71.4%	2.538%
11/9/2018	BlackRock Inc.	889,440	$3.11M	0.0%	+203.2%	1.881%
11/9/2018	Leisure Capital Management	120,940	$0.42M	0.3%	-23.1%	0.256%
10/15/2018	First Manhattan Co.	3,419,269	$11.97M	0.1%	N/A	7.230%
10/3/2018	Acropolis Investment Management LLC	30,000	$0.11M	0.0%	N/A	0.063%
8/9/2018	BlackRock Inc.	293,328	$0.94M	0.0%	+7.7%	0.878%
5/11/2018	Dimensional Fund Advisors LP	69,790	$0.24M	0.0%	N/A	0.209%
5/9/2018	Northern Trust Corp	139,536	$0.49M	0.0%	+50.7%	0.418%
2/10/2018	B. Riley Financial Inc.	232,228	$1.02M	0.3%	N/A	0.696%
2/9/2018	Virtu Financial LLC	100,363	$0.44M	0.0%	N/A	0.301%
2/8/2018	Wells Fargo & Company MN	28,182	$0.12M	0.0%	+1,050.3%	0.084%
11/8/2017	EAM Investors LLC	371,732	$1.94M	0.3%	+58.3%	1.186%
11/8/2017	Granite Investment Partners LLC	87,611	$0.46M	0.0%	N/A	0.279%
11/6/2017	Bank of New York Mellon Corp	27,464	$0.14M	0.0%	+131.0%	0.088%
11/6/2017	Advisor Group Inc.	56,001	$0.29M	0.0%	+149.9%	0.179%
8/15/2017	Stonebridge Capital Advisors LLC	27,500	$0.14M	0.0%	+22.2%	0.100%
8/14/2017	DAFNA Capital Management LLC	24,401	$0.13M	0.1%	-18.7%	0.089%
8/14/2017	First Allied Advisory Services Inc.	22,000	$0.11M	0.0%	N/A	0.080%
8/11/2017	Virtu KCG Holdings LLC	38,474	$0.20M	0.0%	+103.2%	0.140%
8/11/2017	EAM Investors LLC	234,762	$1.22M	0.2%	N/A	0.852%
8/11/2017	Vanguard Group Inc.	942,940	$4.90M	0.0%	+22.2%	3.421%
8/10/2017	Bard Associates Inc.	153,050	$0.80M	0.4%	No Change	0.555%
8/10/2017	Wells Fargo & Company MN	32,500	$0.17M	0.0%	N/A	0.118%
8/9/2017	Leisure Capital Management	145,909	$0.76M	0.7%	+7.2%	0.529%
8/2/2017	Sterling Global Strategies LLC	70,934	$0.37M	1.8%	+66.5%	0.257%
7/31/2017	IFP Advisors Inc	34,433	$0.18M	0.0%	+2,245.6%	0.125%
7/28/2017	State of New Jersey Common Pension Fund D	29,338	$0.15M	0.0%	No Change	0.106%
5/12/2017	Bard Associates Inc.	153,050	$0.65M	0.3%	-1.9%	0.000%
5/12/2017	Axiom International Investors LLC DE	97,040	$1.70M	0.0%	N/A	0.000%
5/12/2017	Sterling Global Strategies LLC	42,600	$0.18M	0.9%	+6.5%	0.000%
5/10/2017	Leisure Capital Management	136,077	$0.58M	0.5%	-2.6%	0.000%
4/26/2017	State of New Jersey Common Pension Fund D	29,338	$0.13M	0.0%	No Change	0.130%
2/14/2017	Bard Associates Inc.	156,000	$0.49M	0.2%	-1.3%	0.723%
2/10/2017	Sterling Global Strategies LLC	40,000	$0.13M	0.5%	+90.5%	0.185%
11/15/2016	Sio Capital Management LLC	665,455	$2.28M	1.6%	-2.8%	3.186%
11/1/2016	Leisure Capital Management	137,132	$0.47M	0.4%	N/A	0.657%
1/13/2016	Creative Planning	0	$0	0.0%	-100.0%	0.000%

Data available starting January 2016

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis. It also offers dry powder inhaler products consisting of fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma; Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California.

Today's Range

Now: $1.12

$1.05

$1.17

50 Day Range

MA: $1.23

$0.70

$1.79

52 Week Range

Now: $1.12

$0.27

$2.34

Volume

5,516,180 shs

Average Volume

29,300,738 shs

Market Capitalization

$150.30 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.68

Who are the company insiders with the largest holdings of Adamis Pharmaceuticals?

Adamis Pharmaceuticals' top insider investors include:

David J Marguglio (SVP)
Dennis J Phd Carlo (CEO)
Robert O Hopkins (CFO)
Ronald B Moss (Insider)
Karen K Daniels (VP)
Robert B Rothermel (Director)
David J Marguglio (SVP)
Dennis J Phd Carlo (CEO)
Karen K Daniels (VP)
Robert O Hopkins (CFO)

Who are the major institutional investors of Adamis Pharmaceuticals?

Adamis Pharmaceuticals' top institutional shareholders include:

GSA Capital Partners LLP — 0.57%
Verdence Capital Advisors LLC — 0.06%

Which major investors are selling Adamis Pharmaceuticals stock?

Within the previous quarter, ADMP stock was sold by these institutional investors:

Verdence Capital Advisors LLC

During the last year, company insiders that have sold Adamis Pharmaceuticals company stock include:

David J Marguglio (SVP)
Dennis J Phd Carlo (CEO)
Robert O Hopkins (CFO)
Ronald B Moss (Insider)
Karen K Daniels (VP)
Robert B Rothermel (Director)
David J Marguglio (SVP)
Dennis J Phd Carlo (CEO)
Karen K Daniels (VP)

Which major investors are buying Adamis Pharmaceuticals stock?

In the previous quarter, ADMP stock was bought by institutional investors including:

GSA Capital Partners LLP